These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 35022172)

  • 1. Twelve-month prevalence of haemarthrosis and joint disease using the Haemophilia Joint Health score: evaluation of the UK National Haemophilia Database and Haemtrack patient reported data: an observational study.
    Wilkins RA; Stephensen D; Siddle H; Scott MJ; Xiang H; Horn E; Palmer B; Chapman GJ; Richards M; Walwyn R; Redmond A
    BMJ Open; 2022 Jan; 12(1):e052358. PubMed ID: 35022172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment regimens and outcomes in severe and moderate haemophilia A in the UK: The THUNDER study.
    Scott MJ; Xiang H; Hart DP; Palmer B; Collins PW; Stephensen D; Sima CS; Hay CRM
    Haemophilia; 2019 Mar; 25(2):205-212. PubMed ID: 30408835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of the Haemophilia Joint Health Score in study of episodically treated boys with severe haemophilia A and B in Lithuania.
    Saulyte Trakymiene S; Ingerslev J; Rageliene L
    Haemophilia; 2010 May; 16(3):479-86. PubMed ID: 20070384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A post hoc comparative real-world analysis of HEAD-US score for joint health assessment of patients with severe haemophilia A and B in Spain.
    Álvarez-Román MT; Jiménez-Yuste V; Martín-Salces M; De la Corte-Rodríguez H; Bonanad S; Núñez R; Fernández-Mosteirín N; García-Frade LJ; Martinoli C; Kim HK
    Haemophilia; 2024 Mar; 30(2):513-522. PubMed ID: 38282205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring joint health in haemophilia: Factors associated with deterioration.
    Kuijlaars IAR; Timmer MA; de Kleijn P; Pisters MF; Fischer K
    Haemophilia; 2017 Nov; 23(6):934-940. PubMed ID: 28873289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment outcomes in persons with severe haemophilia B in the Nordic region: The B-NORD study.
    Kihlberg K; Baghaei F; Bruzelius M; Funding E; Andre Holme P; Lassila R; Nummi V; Ranta S; Osooli M; Berntorp E; Astermark J
    Haemophilia; 2021 May; 27(3):366-374. PubMed ID: 33780113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haemophilia Joint Health Score in healthy adults playing sports.
    Sluiter D; Foppen W; de Kleijn P; Fischer K
    Haemophilia; 2014 Mar; 20(2):282-6. PubMed ID: 24165530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Joint health and treatment modalities in Nordic patients with moderate haemophilia A and B - The MoHem study.
    Måseide RJ; Berntorp E; Astermark J; Olsson A; Bruzelius M; Frisk T; Nummi V; Lassila R; Tjønnfjord GE; Holme PA
    Haemophilia; 2020 Sep; 26(5):891-897. PubMed ID: 33021747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and ultrasound evaluation of patients with haemophilia on prophylaxis.
    Daffunchio C; Galatro G; Rossi M; Landro M; Andreu M; Neme D; Caviglia H
    Haemophilia; 2021 Jul; 27(4):641-647. PubMed ID: 33970513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of pain and functional impairment in US adults with haemophilia: Patient-reported outcomes and musculoskeletal evaluation in the pain, functional impairment and quality of life (P-FiQ) study.
    Kempton CL; Recht M; Neff A; Wang M; Buckner TW; Soni A; Quon D; Witkop M; Boggio L; Gut RZ; Cooper DL
    Haemophilia; 2018 Mar; 24(2):261-270. PubMed ID: 29218759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Joint health and functional ability in children with haemophilia who receive intensive replacement therapy.
    Groen W; van der Net J; Bos K; Abad A; Bergstrom BM; Blanchette VS; Feldman BM; Funk S; Helders P; Hilliard P; Manco-Johnson M; Petrini P; Zourikian N; Fischer K
    Haemophilia; 2011 Sep; 17(5):783-90. PubMed ID: 21790897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Value of routine ultrasound in detecting early joint changes in children with haemophilia using the 'Haemophilia Early Arthropathy Detection with UltraSound' protocol.
    Foppen W; van der Schaaf IC; Fischer K
    Haemophilia; 2016 Jan; 22(1):121-5. PubMed ID: 26228742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The haemtrack home therapy reporting system: Design, implementation, strengths and weaknesses: A report from UK Haemophilia Centre Doctors Organisation.
    Hay CRM; Xiang H; Scott M; Collins PW; Liesner R; Dolan G; Hollingsworth R
    Haemophilia; 2017 Sep; 23(5):728-735. PubMed ID: 28806858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emicizumab prophylaxis in haemophilia A with inhibitors: Three years follow-up from the UK Haemophilia Centre Doctors' Organisation (UKHCDO).
    Wall C; Xiang H; Palmer B; Chalmers E; Chowdary P; Collins PW; Fletcher S; Hall GW; Hart DP; Mathias M; Sartain P; Shapiro S; Stephensen D; Talks K; Hay CRM;
    Haemophilia; 2023 May; 29(3):743-752. PubMed ID: 36811304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of ankle haemarthropathy in patients with moderate haemophilia.
    Wilkins RA; Siddle HJ; Chapman GJ; Horn E; Walwyn R; Redmond AC
    Haemophilia; 2023 Mar; 29(2):600-607. PubMed ID: 36528893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome in moderate haemophilia.
    den Uijl I; Biesma D; Grobbee D; Fischer K
    Blood Transfus; 2014 Jan; 12 Suppl 1(Suppl 1):s330-6. PubMed ID: 23245711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discontinuing early prophylaxis in severe haemophilia leads to deterioration of joint status despite low bleeding rates.
    Nijdam A; Foppen W; De Kleijn P; Mauser-Bunschoten EP; Roosendaal G; van Galen KP; Schutgens RE; van der Schouw YT; Fischer K
    Thromb Haemost; 2016 May; 115(5):931-8. PubMed ID: 26791021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary prophylaxis implementation and long-term joint outcomes in Swedish haemophilia A patients.
    Arvanitakis A; Jepsen C; Andersson NG; Baghaei F; Astermark J
    Haemophilia; 2024 May; 30(3):671-677. PubMed ID: 38575549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Joint status and related risk factors in patients with severe hemophilia A: a single-center cross-sectional study.
    Zhao L; Yang H; Li Y; Wang Z; Zhou L; Zhao X; Peng J
    Hematology; 2022 Dec; 27(1):80-87. PubMed ID: 34964431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue-inhibitors of metalloproteinase-1 and vascular-endothelial growth-factor in severe haemophilia A children on low dose prophylactic recombinant factor VIII: Relation to subclinical arthropathy.
    Andrawes NG; Saker HM; Salah El-Din NY; Abd Elhakim Hussain M
    Haemophilia; 2020 Jul; 26(4):607-614. PubMed ID: 32445517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.